CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. Interest Expense Nonoperating
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. (CBIH) reported Interest Expense Nonoperating of $10.78 thousand for the 3-month period ending 2026-02-28, per its 10-Q filed 2026-04-16.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-04-16
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. interest expense nonoperating for the quarter ending 2026-02-28 was $10.78K, a 52.05% decline year-over-year.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. interest expense nonoperating for the quarter ending 2025-11-30 was $17.86K, a 105.26% increase year-over-year.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. interest expense nonoperating for the quarter ending 2025-08-31 was $17.37K, a 642.54% increase year-over-year.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. interest expense nonoperating for the quarter ending 2025-05-31 was $102.75K, a 7.81% increase year-over-year.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. interest expense nonoperating for fiscal 2025 was $136.26K, a 11.64% decline from fiscal 2024.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. interest expense nonoperating for fiscal 2024 was $154.21K, a 69.51% increase from fiscal 2023.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. interest expense nonoperating for fiscal 2023 was $90.97K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-02-28 | $10.78K 10-Q · filed 2026-04-16 | $28.64K derived: sum of 2 quarters · filed 2026-04-16 | $46.00K 10-Q · filed 2026-04-16 | $148.75K derived: sum of 4 quarters · filed 2026-04-16 |
| 2025-11-30 | $17.86K 10-Q · filed 2026-02-19 | $35.23K 10-Q · filed 2026-02-19 | $137.98K derived: sum of 3 quarters · filed 2026-02-19 | $160.45K derived: sum of 4 quarters · filed 2026-04-16 |
| 2025-08-31 | $17.37K 10-Q · filed 2025-10-22 | $120.12K derived: sum of 2 quarters · filed 2025-10-22 | $142.59K derived: sum of 3 quarters · filed 2026-04-16 | $151.29K derived: sum of 4 quarters · filed 2026-04-16 |
| 2025-05-31 | $102.75K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-22 | $125.22K derived: sum of 2 quarters · filed 2026-04-16 | $133.92K derived: sum of 3 quarters · filed 2026-04-16 | $136.26K 10-K · filed 2025-09-22 |
| 2025-02-28 | $22.47K 10-Q · filed 2026-04-16 | $31.17K derived: sum of 2 quarters · filed 2026-04-16 | $33.51K 10-Q · filed 2026-04-16 | $128.81K derived: sum of 4 quarters · filed 2026-04-16 |
| 2024-11-30 | $8.70K 10-Q · filed 2026-02-19 | $11.04K 10-Q · filed 2026-02-19 | $106.34K derived: sum of 3 quarters · filed 2026-02-19 | $155.56K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-08-31 | $2.34K 10-Q · filed 2025-10-22 | $97.64K derived: sum of 2 quarters · filed 2025-10-22 | $146.86K derived: sum of 3 quarters · filed 2025-10-22 | |
| 2024-05-31 | $95.30K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-22 | $144.52K derived: sum of 2 quarters · filed 2025-09-22 | $154.21K 10-K · filed 2025-09-22 | |
| 2024-02-29 | $49.22K 10-Q/A · filed 2025-05-09 | $58.90K 10-Q/A · filed 2025-05-09 | ||
| 2023-08-31 | $5.00K 10-Q · filed 2024-10-21 | |||
| 2023-05-31 | $90.97K 10-K · filed 2024-09-16 |